Skip to main content

Orion Biotech Opportunities Corp. (ORIA)

NASDAQ: ORIA · Delayed Price · USD
9.68
-0.32 (-3.20%)
After-hours:Oct 20, 2021 4:00 PM EDT
10.00
0.00 (0.00%)
At close: Oct 19, 12:00 AM
Market Cap250.00M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out25.00M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2
Open-
Previous Close10.00
Day's Range9.68 - 10.00
52-Week Range9.45 - 10.78
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About ORIA

Orion Biotech Opportunities is a newly incorporated blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to focus on the biotechnology and life sciences industries. In particular, we will target North American, European, and Asian healthcare companies with the potential to drive transformational change through the development and commercialization of nove...

IndustryBlank Check / SPAC
IPO DateMay 13, 2021
CEOJames Huang
Employees2,021
Stock ExchangeNASDAQ
Ticker SymbolORIA
Full Company Profile

News

Orion Biotech Opportunities Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commenci...

NEW  YORK, July 1, 2021 /PRNewswire/ -- Orion Biotech Opportunities Corp. (Nasdaq: ORIAU) (the "Company" or "us") announced that, commencing July 2, 2021, holders of the units sold in the Company's init...

3 months ago - PRNewsWire

Orion Biotech Opportunities Corp. Announces Pricing of $200,000,000 Initial Public Offering

NEW YORK, May 12, 2021 /PRNewswire/ -- Orion Biotech Opportunities Corp. (the "Company") today announced the pricing of its initial public offering ("IPO") of 20,000,000 units at a price of $10.00 per u...

5 months ago - PRNewsWire

MSD Partners and Panacea's SPAC Orion Biotech Opportunities files for a $200 million IPO

Orion Biotech Opportunities, a blank check company formed by MSD Partners and Panacea Venture targeting the biotech and life science sectors, filed on Thursday with the SEC to raise up to $200 million i...

7 months ago - NASDAQ

Orion Biotech Opportunities IPO Registration Document (S-1)

Orion Biotech Opportunities Corp. has filed to go public with an IPO on the NASDAQ.

7 months ago - SEC